Stonnington Group LLC Boosts Stock Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)

Stonnington Group LLC grew its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Rating) by 164.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,200 shares of the biopharmaceutical company’s stock after acquiring an additional 8,200 shares during the period. Stonnington Group […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,United States ,Canada ,Blackrock ,America ,Mark Neumann ,Lawrencej Hineline ,Securities Exchange Commission ,Blackrock Inc ,Stonnington Group ,Lord Abbett ,Cantor Fitzgerald ,Wellington Management Group ,Vanguard Group Inc ,Needham Company ,Cellular Therapies Inc ,Royal Bank ,Nasdaq ,Intra Cellular Therapies ,Get Rating ,Management Group ,Cellular Therapies ,Exchange Commission ,Intra Cellular Therapies Daily ,